The gut stuff caught me completely off guard. Nobody warned me that estrogen dropping could make my digestion go sideways, my skin flare up, and my immune system feel like it was running on fumes — all at the same time. When I started reading about how the gut lining actually depends on estrogen to stay intact, colostrum suddenly made a lot more sense to me as something worth investigating properly.
Learn more about Rose →Estrogen plays a direct role in maintaining tight junction proteins, the microscopic gatekeepers that keep the intestinal lining sealed against pathogens and undigested particles. When estrogen declines in perimenopause, tight junction integrity can deteriorate — a phenomenon increasingly linked to systemic inflammation, food sensitivities, and immune dysregulation. Bovine colostrum contains proline-rich polypeptides (PRPs) and growth factors including IGF-1 and TGF-β that have been shown in multiple studies to support tight junction repair and reduce intestinal permeability markers.
Roughly 70% of the immune system is housed in gut-associated lymphoid tissue, and that relationship becomes increasingly important as menopause shifts immune balance toward a more pro-inflammatory state. Bovine colostrum is exceptionally rich in immunoglobulins — particularly IgG, IgA, and IgM — which help neutralise pathogens in the gut lumen and support secretory immune responses without overstimulating systemic inflammation. Research in healthy adults has shown that colostrum supplementation can meaningfully increase salivary IgA levels, a key marker of mucosal immune defence.
Lactoferrin is an iron-binding glycoprotein found in high concentrations in bovine colostrum, and it has a well-documented ability to bind iron that would otherwise feed pathogenic bacteria, effectively starving them out. Beyond its antimicrobial role, lactoferrin modulates inflammatory cytokine signalling — particularly relevant during menopause, when estrogen-driven suppression of NF-κB inflammatory pathways is reduced. Several randomised controlled trials have demonstrated lactoferrin's capacity to reduce circulating markers of inflammation including IL-6 and CRP, both of which tend to rise in the menopausal transition.
Estrogen has an underappreciated role in promoting muscle protein synthesis and reducing protein breakdown, which is why the menopausal transition is accompanied by accelerated loss of lean muscle mass — a process called sarcopenia. Bovine colostrum contains meaningful concentrations of insulin-like growth factor 1 (IGF-1), a signalling molecule that directly stimulates muscle protein synthesis and satellite cell activity. Studies in older adults and athletic populations have found colostrum supplementation associated with preserved or increased lean mass compared to whey protein controls, though menopause-specific trials remain limited.
Estrogen and the gut microbiome are in constant two-way communication through a specialised community of bacteria called the estrobolome, which helps regulate estrogen metabolism and recirculation. After menopause, microbiome diversity typically falls, populations of protective Lactobacillus species decline, and opportunistic bacteria can take hold — a pattern associated with increased systemic inflammation and even altered mood. Colostrum's combination of oligosaccharides (acting as prebiotics), antimicrobial peptides, and immune-modulating proteins creates an intestinal environment more favourable to beneficial microbial populations, with emerging human data supporting improvements in microbiome diversity scores.
The mucosal lining of the gastrointestinal tract undergoes measurable thinning with age and reduced hormone exposure, affecting both its protective and absorptive functions. Transforming growth factor beta (TGF-β) and epidermal growth factor (EGF), both present in bovine colostrum, are known to stimulate intestinal epithelial cell proliferation and accelerate mucosal repair after damage. This is the same physiological mechanism exploited in research using colostrum to reduce gut damage caused by NSAIDs and intense exercise — models that share features with the age- and hormone-related mucosal changes seen in menopausal women.
The chronic low-grade inflammation that rises during and after menopause — sometimes called inflammaging — is increasingly understood as a root driver of symptoms ranging from joint pain and brain fog to cardiovascular risk and metabolic changes. Bovine colostrum's PRPs, lactoferrin, and cytokine-modulating immunoglobulins appear to work in concert to dial down this baseline inflammatory signal rather than simply suppress immune activity broadly. Small human trials have reported reductions in pro-inflammatory cytokines following colostrum supplementation, though most studies are short-duration and conducted in non-menopausal populations, meaning extrapolation requires caution.
IGF-1 is one of the key anabolic signals in bone remodelling, stimulating osteoblast activity and suppressing osteoclast-driven bone breakdown — the very balance that tips unfavourably when estrogen disappears. Bovine colostrum delivers bioavailable IGF-1 alongside calcium, phosphorus, and bone-relevant growth factors, and at least one small randomised trial found colostrum supplementation associated with attenuated bone resorption markers compared to placebo. This is an emerging area and colostrum should not be framed as a primary bone-protection strategy, but the mechanistic rationale places it in the same conversation as other adjunctive nutritional approaches to bone health.
Human trials using bovine colostrum have reported a reassuring safety profile, with the most common adverse effects being mild gastrointestinal bloating during the first week of use — typically resolving as the gut adapts. However, the biological activity of colostrum is highly sensitive to how it is collected and processed: heat pasteurisation above certain temperatures degrades immunoglobulins and growth factors significantly, meaning low-temperature or cold-processed products preserve more of the functional compounds the evidence actually relates to. Women with dairy allergies or sensitivities should approach with caution, and anyone on immunosuppressive therapy should discuss colostrum supplementation with their prescribing clinician before starting.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.